REPLIGEN CORP 4
4 · REPLIGEN CORP · Filed Mar 22, 2017
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Benjamin Howard
Other
Transactions
- Exercise/Conversion
Common Stock
2017-03-20$15.91/sh+4,968$79,041→ 36,124 total - Sale
Common Stock
2017-03-20$34.61/sh−4,968$171,944→ 31,156 total - Sale
Common Stock
2017-03-20$34.63/sh−7,248$251,010→ 23,908 total - Exercise/Conversion
Common Stock
2017-03-20$6.23/sh+10,000$62,300→ 33,908 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-20−4,968→ 0 totalExercise: $15.91Exp: 2024-02-27→ Common Stock (4,968 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-20−10,000→ 0 totalExercise: $6.23Exp: 2023-02-28→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]$34.6103 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]$34.6316 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.475 to $34.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This option is currently exercisable.